Friday, October 05, 2007 12:27:04 PM
Bruker BioSciences Rises After Bear Stearns Upgrades Stock, Predicts Earnings Growth Into 2009
October 05, 2007: 10:31 AM EST
NEW YORK (Associated Press) - Shares of Bruker BioSciences Corp., which makes X-ray technology and molecular analysis tools, climbed Friday after a Bear Stearns analyst upgraded the stock, saying the company's profit should grow 30 percent in both 2008 and 2009.
Stephen Unger raised his rating to "Outperform," or "Buy," from "Peer Perform," and said the stock should rise to $12 by the end of 2008. He expects the company to report an adjusted profit of 23 cents per share this year, matching last year's results.
Unger forecast profit of 30 cents per share in 2008 and 39 cents per share in 2009. He said Bruker's revenue should grow more than 10 percent per year over that time, and its profit margins will increase.
The stock picked up 53 cents, or 6.2 percent, to $9.13. Unger's price target implies 39.5 percent growth from Bruker's Thursday closing price of $8.60.
The weak U.S. dollar is good news for Bruker, Unger said in a client note, as about 75 percent of its revenue _ and all of its operating profit _ comes from overseas. Almost half of its total profit comes from Germany, he added, and starting in 2008, Bruker will be able to pay lower taxes in the country.
Analysts polled by Thomson Financial expect Bruker to earn 33 cents per share in 2008 and 43 cents per share the next year.
Three analysts now rate the Billerica, Mass., company at "Buy," and one assigns a "Neutral" rating.
http://tinyurl.com/2j49fg
Recent BRKR News
- Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery • Business Wire • 10/02/2024 11:00:00 AM
- Bruker Corporation to Present at Upcoming Investor Conferences • Business Wire • 08/23/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 08:39:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 09:41:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:40:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:39:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:38:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:37:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:36:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:35:48 PM
- Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI) • Business Wire • 08/13/2024 05:35:00 PM
- Bruker Announces Quarterly Dividend • Business Wire • 08/12/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 08:03:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:30:50 PM
- Bruker Announces Strategic Minority Investment in NovAliX • Business Wire • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:00:08 AM
- Bruker Reports Second Quarter 2024 Financial Results • Business Wire • 08/06/2024 11:00:00 AM
- Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast • Business Wire • 07/31/2024 08:05:00 PM
- Bruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately • Business Wire • 07/18/2024 11:00:00 AM
- Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin • Business Wire • 07/02/2024 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/05/2024 08:30:30 PM
- Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications • Business Wire • 06/03/2024 11:00:00 AM
- Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics • Business Wire • 06/03/2024 11:00:00 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM